The 190-bed hospital is owned by Americore Holdings, a Florida-based hospital management firm that filed for bankruptcy in December 2019. Americore has three hospitals.
In July, the bankruptcy court overseeing the case approved a proposal for Americore to sell St. Alexius Hospital and its assets to SA Hospital Acquisition Group. The sale of St. Alexius was expected to close no later than Aug. 21, according to the report.
However, the potential buyer said it doesn’t want to finalize the sale until the investigation into patient care is resolved.
The Missouri Department of Health and Senior Services began its probe after receiving an anonymous complaint about the quality of care at the hospital, which treats a large portion of Medicare and Medicaid patients.
The state department’s health inspectors visited the facility in August. After the visit, the facility was placed in immediate patient jeopardy, which is a situation where a patient suffered serious harm or could suffer serious harm based on the hospital’s practices and procedures. The specific patient care issues identified by regulators were not publicly available.
St. Alexius has submitted a plan of correction to fix the issues identified by state regulators, but a Missouri health department spokesperson said the investigation is still ongoing.
The sale of another hospital owned by Americore, Ellwood (Pa.) City Medical Center, is also in limbo, according to the Ellwood City Ledger.
There was no suitable outside buyer identified for the Pennsylvania hospital, which closed last December. This means its top creditor, Pelorus Equity Group, may be handed ownership, according to the report.
Although Pelorus Equity may become the owner, the group would need to find a company to operate the hospital before it could reopen.
The third hospital owned by Americore, Izard County Medical Center in Calico Rock, Ark., has three prospective buyers, according to court documents cited by the Ledger.
More articles on healthcare industry transactions:
Illinois system to join Northwestern Medicine
FTC urges Texas regulators to block CHS’ divestiture of 2 hospitals
Hospital M&A update: 11 recent deals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit